Bharat Parenterals Ltd
NSE: BSE: 541096
₹1084.90
(4.40%)
Wed, 11 Mar 2026, 09:00 am
Market Cap7.16B
PE Ratio0
Dividend0.09
Health Technology
Pharmaceuticals: Major
24.5KBharat Parenterals Income Statement
| Particulars | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 1.14B | 1.19B | 1.20B | 1.11B | 1.37B | 2.20B | 2.28B | 2.05B | 2.12B | 2.18B | 2.59B | 3.37B |
| Gross profit | 181.48M | 174.00M | 190.10M | 93.76M | 231.90M | 477.33M | 475.86M | 403.24M | 435.85M | 430.21M | 512.23M | 231.90M |
| Operating expenses (excl. COGS) | -60.76M | -70.00M | -79.72M | -84.57M | -163.90M | -245.33M | -248.75M | -203.01M | -208.09M | -276.76M | -339.44M | -570.50M |
| Selling/general/admin expenses, total | -103.06M | -105.30M | -123.76M | -84.36M | -163.27M | -244.67M | -247.39M | -201.95M | -207.63M | -276.59M | -328.40M | -562.64M |
| Research & development | -3.04M | -8.78M | -7.56M | -7.08M | -12.93M | -22.73M | -21.62M | -17.10M | -14.19M | -10.49M | -17.03M | -65.14M |
| Selling/general/admin expenses, other | -100.01M | -96.52M | -116.21M | -77.28M | -150.34M | -221.94M | -225.77M | -184.85M | -193.45M | -266.10M | -311.37M | -497.50M |
| Other operating expenses, total | 42.29M | 35.30M | 44.04M | -205.00K | -626.00K | -657.00K | -1.36M | -1.06M | -453.00K | -176.00K | -11.04M | -7.86M |
| Operating income | 120.71M | 104.00M | 110.38M | 9.20M | 68.00M | 232.00M | 227.12M | 200.23M | 227.76M | 153.45M | 172.79M | -338.61M |
| Non-operating income, total | -57.35M | -16.91M | -16.93M | 65.60M | 59.91M | 88.65M | 100.84M | 71.02M | 51.00M | 82.02M | 14.43M | -900.00K |
| Interest expense, net of interest capitalized | -14.19M | -21.32M | -14.86M | -9.06M | -9.40M | -8.70M | -8.65M | -7.65M | -13.06M | -25.96M | -40.10M | -129.29M |
| Interest capitalized | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Non-operating income, excl. interest expenses | -25.98M | 4.41M | -2.37M | 75.06M | 69.85M | 110.31M | 107.16M | 68.99M | 52.72M | 110.03M | 53.98M | 129.44M |
| Non-operating interest income | 2.18M | 2.79M | 2.26M | 3.64M | 1.99M | 2.45M | 4.68M | 3.54M | 16.75M | 3.38M | 4.25M | 37.66M |
| Miscellaneous non-operating expense | -28.15M | 1.62M | -4.62M | 71.41M | 67.85M | 107.86M | 102.49M | 65.44M | 35.97M | 106.65M | 49.73M | 91.78M |
| Unusual income/expense | -17.18M | 0 | 299.95K | -401.00K | -533.00K | -12.97M | 2.33M | 9.69M | 11.34M | -2.05M | 545.00K | -1.05M |
| Pretax income | 63.36M | 87.09M | 93.46M | 74.79M | 127.92M | 345.93M | 327.96M | 271.25M | 278.77M | 235.47M | 187.22M | -339.51M |
| Taxes | 2.09M | -12.70M | -28.92M | -5.85M | -36.76M | -133.45M | -86.53M | -68.08M | -70.65M | -78.32M | -82.07M | -97.25M |
| Non-controlling/minority interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 728.00K | 2.41M | 7.26M | 40.03M | 310.49M |
| After tax other income/expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income before discontinued operations | 65.46M | 74.38M | 64.53M | 68.94M | 91.16M | 212.47M | 241.43M | 203.89M | 210.53M | 164.40M | 145.17M | -126.26M |
| Net income | 65.46M | 74.38M | 64.53M | 68.94M | 91.16M | 212.47M | 241.43M | 203.89M | 210.53M | 164.40M | 145.17M | -126.26M |
| Dilution adjustment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Preferred dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted net income available to common stockholders | 65.46M | 74.38M | 64.53M | 68.94M | 91.16M | 212.47M | 241.43M | 203.89M | 210.53M | 164.40M | 145.17M | -126.26M |
| Basic earnings per share (Basic EPS) | - | - | - | - | - | - | - | - | - | - | - | - |
| Diluted earnings per share (Diluted EPS) | - | - | - | - | - | - | - | - | - | - | - | - |
| EBITDA | 151.03M | 146.16M | 152.42M | 67.10M | 123.73M | 292.70M | 285.94M | 259.31M | 293.28M | 211.28M | 262.99M | 14.61M |
| EBIT | 120.71M | 104.00M | 110.38M | 9.20M | 68.00M | 232.00M | 227.12M | 200.23M | 227.76M | 153.45M | 172.79M | -338.61M |
| Total operating expenses | -1.02B | -1.08B | -1.09B | -1.11B | -1.30B | -1.96B | -2.05B | -1.85B | -1.89B | -2.03B | -2.42B | -3.71B |
| Prepaid expenses | 1.67M | 1.34M | 1.20M | 1.04M | 1.35M | 1.97M | 2.20M | 6.21M | 13.32M | 13.38M | 15.49M | 20.77M |
| Deferred income, current | 3.01M | 5.58M | 1.26M | 657.00K | 79.06M | 41.76M | 13.70M | 11.79M | 21.07M | 74.61M | 143.18M | 70.74M |
| Capital and operating lease obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating lease liabilities | — | — | — | — | — | — | — | — | — | — | — | — |
| Deferred tax liabilities | 18.27M | 11.42M | 4.95M | 0 | 216.00K | 35.42M | 24.39M | 22.65M | 17.77M | 14.26M | 13.35M | 11.41M |
| Deferred income, non-current | — | — | — | — | — | — | — | — | — | — | — | 2.65M |
| Minority interest | 0 | 0 | 0 | 1.00K | 1.00K | 1.00K | 1.00K | -483.00K | 43.17M | 351.03M | 409.07M | 83.25M |
| Change in accrued expenses | — | — | — | — | — | — | — | — | — | — | — | — |
| Common dividends paid | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -4.33M | -5.82M |
| Preferred dividends paid | — | — | — | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800